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Background: Prescribing that is not concordant with guidelines is increasingly referred to as clinical inertia (CI).
However, CI may be only apparent, and the absence of decision may actually reflect appropriate inaction as a result
of good clinical reasoning. Our study aimed to: (i) elucidate GPs’ beliefs regarding CI and the risk of CI in their own
practice, (ii) identify modifiable provider-related factors associated with CI.
Methods: We conducted 8 group interviews with 114 general practitioners (GP) in Belgium, and used an integrated
approach of thematic analysis.
Results: Our results call for a redefinition of CI, in order to take into account the GPs’ extended health-promoting
role, and acknowledge that inaction or delayed action follows a process of clinical reasoning that takes into account
the patients’ preferences, and that is appropriate most of the time. However, the participants in our study did
acknowledge that the risk of CI exists in practice. The main factor of such a risk is when GPs feel overwhelmed
and disempowered, due to characteristics of either the patients or the health care system, including contradictions
between guidelines and reimbursement policies.
Conclusions: Although situations of clinical inertia exist in practice and need to be prevented or corrected, the
term clinical inertia could potentially increase the already existing gap between general practice and specialised
care, whereas sustained efforts toward more collaborative work and integrated care are called for.Background
Failure to treat to target, or prescribing that is not con-
cordant with guidelines are increasingly being referred
to as clinical inertia (CI). Phillips et al. [1] first coined
the term, which they defined as a failure to initiate or in-
tensify therapy when indicated, or a failure to act despite
recognition of the problem [1]. Alongside patient non-
adherence to treatments, CI is believed to be a major fac-
tor that contributes to inadequate management of chronic
conditions [2,3]. It has been suggested that CI related to
management of diabetes, hypertension and lipid disorders
may contribute up to 80% of heart attacks and strokes [4].
As it associates with poor control of risk factors known to* Correspondence: isabelle.aujoulat@uclouvain.be
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unless otherwise stated.cause long-term health problems, CI has an economic im-
pact alongside medical consequences [5-7].
O’Connor et al. [2] postulated three classes of factors
leading to CI: factors related to (i) providers, (ii) pa-
tients, and (iii) the system, with an estimated relative
contribution of 50%, 30% and 20% respectively [2].
Other authors report up to 75% provider-related factors
[8]. The three provider-related factors that were initially
defined by Phillips et al. [1] are assumed to be the most
common contributors to CI [2,4,9]: (i) providers’ overesti-
mation of the care they give; (ii) providers’ use of ‘soft’ rea-
sons to avoid therapy; (iii) providers’ lack of education,
training or organisation for achieving therapeutic goals.
This list of factors is of little help in overcoming CI in
practice. Indeed, practitioners need to be helped to over-
come CI rather than systematically blamed for inaction
[10], the latter being otherwise occasionally appropriate.
Indeed, as summarised by Reach [11], clinical inactionl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Participants’ characteristics (n = 114)
n(%) Median
(range)
Gender
Male 67(58,8)
Female 47(41,2)
Type of practice
Single-handed practice 73(64)
Group practice 34(29,5)
Mixed (people working in more than one practice) 7(6,5)
Setting
Urban 66(58)
Rural 48(42)
Work experience
Median duration of work experience 31,3(2–40)
GPs with less than 10 years of practice 11(9,6)
GPs with over 35 years of practice 17(15,5)
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ists; (ii) the provider knows the recommendation; (iii)
the provider believes the recommendation applies to the
patient; (iv) the provider has the necessary resources to
apply the recommendation; (v) the provider does not
apply the recommendation for a particular patient, even
though the conditions 1 to 4 are present [11]. Following
this definition, non-adherence to guidelines may corres-
pond to appropriate inaction as a result of good clinical
reasoning. As shown in our recent literature review [12],
actual CI is therefore difficult to observe and distinguish
from appropriate inaction. It should not be evidenced
without a careful investigation of a practitioner’s reason-
ing underlying their decisions. Moreover, in order to
help anticipate the risk of CI in practice, it is necessary
to understand which modifiable and non-modifiable
factors underlie CI. Our study aimed to elucidate GPs’ be-
liefs regarding the risk of CI in their own practice, and
personal modifiable factors associated with the risk of CI.
Methods
We conducted an exploratory qualitative study through
group interviews among a sample of general practi-
tioners (GP) in the Wallonie-Bruxelles Region (the
French speaking part of Belgium). All participants were
members of the same scientific society (Société Scientifi-
que de Médecine Générale - SSMG). Over 40% of all
GPs in the French speaking part of Belgium are mem-
bers of SSMG, thus ensuring truthworthiness of our
study. As part of their vocational training, members of
SSMG from a same geographical area meet regularly
around topics of interest to their practice. We used the
opportunity of these existing practice-sharing encounters
to conduct our interviews. In accordance with the local
group coordinators, the GPs were informed beforehand
of the topic of the discussion through a letter co-signed
by the first author (IA) and the medical coordinator of
SSMG. The practitioners who accepted to participate in
our study were asked to inform the coordinator of their
group that they would participate. We opted for inter-
views during such formal natural groups [13], rather
than purposively sampled groups, as we hypothesized
that the GPs would feel more comfortable discussing the
issues surrounding CI in the familiar setting of their
regular meetings. Our sample involved a total of 114
GPs in 8 group interviews, between October and De-
cember 2012. After the 5 first focus groups, a meeting of
the steering committee (co-authors) was organised in
order to refine the emerging themes and discuss impli-
cations for practice. After 3 more focus groups, as no
new themes emerged, descriptive saturation of data was
reached. The participants’ characteristics are shown in
Table 1. Although sampling representativeness may be a
less important issue in qualitative research, it is worthstressing that the male/female ratio among the partici-
pants in our sample (58.9/41.2) was the same than the
male/female ratio among the members of SSMG (59/41).
Data collection
A standardised procedure was adopted for the data col-
lection in every group. Two researchers were present at
every meeting, and moderated the focus group discus-
sions: The first author would introduce the topic with a
brief review of the literature on IC. The group discussion
would then be moderated by the second author. The re-
search interviews were guided by two categories of
open-ended questions consistent with the objectives of
the study: (i) GPs’ beliefs regarding the risk of CI in their
own practice, (ii) factors associated with CI. The dur-
ation of the discussions was limited to two hours. At the
end of every focus group, there was a debriefing between
the two researchers to discuss the most important
themes that had emerged, and possible similarities and
differences to other focus groups.
Data analysis
All focus groups were audio-taped and transcribed ver-
batim for analysis. As part of a process of respondent
validation and error reduction, every participant received
a synthesis of their group’s discussion, and was invited
to share comments or further information directly with
the researchers, either over the phone or by e-mail. We
received feedback from six (6) participants, representing
5 different groups. Three (3) participants thanked the re-
searchers for the discussion and the follow-up, and for-
mally validated the synthesis. Two participants explained
how the ideas shared during the focus group were
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had made him personally more aware of the risk of CI in
his own practice. The last participant informed the re-
searchers of a TV programme relevant to the topic of CI.
The participants’ comments did not add much to our ana-
lysis in terms of thematic contents, but confirmed the
relevance of addressing the sensitive issue of CI with GPs.
The transcripts were analysed using an integrated ap-
proach of categorisation: A start list of two codes reflect-
ing the research objectives was used as a framework to
organise the thematic categories that were inductively
created through careful revision of the transcribed ma-
terial [14,15]. To ensure validity of the findings and in-
terpretations, the first and second authors independently
coded the transcripts and met at regular intervals to dis-
cuss emerging categories. As already stated, the mem-
bers of the steering committee (co-authors) were invited
to reflect and comment on the analysis process after 5
focus groups. The study was stopped after 8 groups, as
no new themes were emerging, meaning that descriptive
saturation was achieved. Our results hereafter are il-
lustrated with individual quotations from the various
focus-groups [16].
Ethics
Our study did not involve any patients nor patients’ rela-
tives, nor did it require that patient data be shared with
the researchers. Our study does therefore not fall within
the scope of the Belgian Law of 7 May 2004 on Human
experiments, and did therefore not require the approval
of an ethics committee, nor that informed consent forms
be signed by the participants.
Ethical considerations were present however at all
stages of the project: Every GP was personally informed
of the study and invited to knowingly join (or not) the
focus group interview several weeks before the encoun-
ter; the interview process was conducted with a non-
judgmental attitude and was very respectful of the GPs’
perceptions and self-reported experiences regarding the
phenomenon of CI in their own practice; last but not
least, every GP within a group was sent a synthesis of
the discussion within that group, and was thus given the
possibility to comment personally, either by e-mail or
over the phone, on the synthesis of their interview.
Results
GPs’ beliefs regarding CI and the risk of CI in their own
practice
To initiate a discussion about CI in general practice
raised mixed feelings. It initially made most participants
uneasy. In addition to questioning the applicability of
guidelines in some situations, the concept of “double-
bind” was raised to explain GPs’ difficulty in complying
with guidelines in some occasions. Moreover, the GPs’called for a redefinition of CI, in order to take into ac-
count their health-promoting role and to acknowledge
that most decisions are taken as a result of a complex
process of clinical reasoning, and should not be mis-
taken for CI.
Mixed feelings and perceptions of a double-bind
The GPs generally expressed mixed feelings about the
concept of CI, which was new to them. On the one
hand they saw the discussion on CI as very interesting,
stimulating, and revealing: “it encourages us to look at
our own practice through a critic’s eye” (FG6). Or: “Now
that I am aware of the risk of CI, will I look differently
at my files? Will I change my practice or examine more
critically why I don’t change it? I am curious to see
what happens…” (FG4). On the other hand, the topic
raised feelings of unease and guilt: “It’s about what we
should do, but currently do not do (…) it’s about feeling
guilty for not doing well in some occasions” (FG1).
Quite often the term was even perceived as insulting:
“It’s a very negative term. It conveys that we are pas-
sive, that we don’t do anything… (FG4)”. According to
the GPs, the message that is implicitly conveyed with
CI is that GPs need to prescribe more. This injunction
was perceived as being in total contradiction with the
need to comply at the same time with the healthcare
system’s demand to reduce costs. The concept of
“double-bind” was raised to describe the complexity of
the GPs’ role and their feelings of powerlessness
in some situations: “If we strictly prescribed everything
as recommended in the guidelines…wouldn’t we be
blamed for over-prescribing compared to our colleagues,
thus impacting negatively on the budget of the healthcare
system?” (FG4).
To care for patients and promote their health, rather than
to treat to target
The narrow definition around prescribing to target, was
perceived by the GPs as too restrictive in the context of
general practice: “A patient cannot be reduced to figures!
Figures alone cannot reflect the complexity of clinical
cases. Every situation is unique! We do have targets for
our patients, but targets need to be adapted to every pa-
tient’s individual situation” (FG2). The participants be-
lieved that a relevant definition of CI needs to include
the GPs’ health-promoting role, in addition to that of
treating patients. For instance, GPs acknowledged the
presence of CI in situations where they might fail to pro-
vide timely preventative messages or adequate psycho-
social support. They insisted that their role is to care for
patients, which is a much broader objective than that of
treating to target: “When my patient is a 75 year-old
women with a blood pressure as high as 150 (mmHg), I
leave her alone! If she is happy to eat a little piece of cake
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is 130 (mg/dL)…well, I won’t bother putting her on medi-
cation in order to lower her blood sugar level to 100, and
her blood pressure to 13” (FG7). Guidelines were gener-
ally acknowledged as providing state of the art know-
ledge and were considered very important in indicating
a direction rather than presenting a goal to achieve.
However, the GPs expressed concern because of a great
number of changing and sometimes contradictory guide-
lines, making it difficult to know what to do in some sit-
uations. They also pointed out the fact that highly
specialised guidelines may not offer sufficient guidance
in cases of co-morbidity. Moreover, the validity of guide-
lines was questioned by some who thought that new
guidelines might be issued in relation with the marketing
of new pharmaceutical products.
Appropriate inaction versus “true” CI
There was a strong consensus both within the various
groups and across the groups that the “failure to initiate
or intensify a treatment according to guideline” is a
common occurrence in general practice. However, the
participants agreed that most decisions are taken after
careful examination of the patients’ lives, personal objec-
tives, possibilities and preferences, etc. Moreover, the de-
cision not to prescribe more is justified in situations
where the patient is already on a number of different
drugs and GPs are aware that the prescription of a new
drug might increase the risk of non-adherence or of los-
ing track of a patient. Such decisions should be seen as
the result of an appropriate decision following a complex
process of clinical reasoning, rather than a manifestation
of CI: “It’s like playing chess: you need to move your
pawns step by step to achieve the best results possible in-
stead of charging straight for the king… one move at a
time. You mustn’t try to win the game in one go (…) Of
course we have targets for our patients, but we adjust
them for each individual patient”. (FG2)
The participants in our study did however acknow-
ledge that the risk of CI exists in practice: “Some pa-
tients do not understand what we mean if we don’t take
at least 15 minutes to explain and explain again…We
happen to be fed up, and not bother to explain twice.…
there we may be blamed for CI”. (FG7)
Personal risk factors of CI
Across a variety of situations, a sense of being over-
whelmed and feelings of disempowerment were the main
common factors associated with the risk of CI.
Feeling overwhelmed
The lack of timely investigation to recognise and treat a
problem emerged as the most common manifestation of
CI, and was reported to be mainly due to factors ofhuman error, such as tiredness, conflicting priorities
(private and professional), lack of time, etc. “At the end
of the day, after you saw 20, 30, 35 patients…you had a
hard day. If you then see a patient with borderline
values, a blood pressure that is not optimal, well, you
tend to minimise a bit, you tend to convince yourself that
it’s not the right time,that you’ll look at it next time. It’s
not an excuse, but nobody is perfect. We also have our
children to pick up at school or other conflicting prior-
ities…” (FG5).
Another reason for not investigating further during a
consultation was linked to the attitude of some patients
who address multiple demands to the doctor, either for
themselves or for other family members: “Tonight, one of
my last patients came because she had flu. She came
with her son and husband. At the end of the visit she
asked: “Did you receive my son’s and my husband’s blood
tests?” By the way, the tests had been done two months
ago. The son was OK, but the husband had type 2 dia-
betes, and his results were not brilliant. I still had one
other patient to see before I could go home, prepare sup-
per for my son, and get ready to be on time for our meet-
ing tonight. I told the patient to come back”. (FG8)
Regarding CI in relation to prescribing medication, an
issue frequently reported was that of the amount of ad-
ministrative work requested for some particular pre-
scriptions: “You are aware that you should be doing
something, but you don’t. Why is that? Because you are
tired, because you need to find the right form…I tell you
what -as far as I am concerned, my CI is mainly related
to paperwork. If I want to prescribe paracetamol, and I
need to find the form, which of course is at the bottom of
the pile, for the patient to pay 1,50 instead of 3,50…well,
sometimes I feel it’s not worth the effort”. (FG7)
Feeling disempowered
A sense of powerlessness was reported to be involved in
CI. Patients who are particularly difficult to treat because
they are non-adherent, for instance, or aggressive, or
denying their medical needs, etc. may induce a sense of
powerlessness on the part of the physicians. “We are
there to explain, we take some time with them to explain
what their problem is, what diet they should adhere to,
what they are exposed to if they don’t change their
habits…yet, they do what they want…We do try to in-
crease their motivation regularly. But after some time,
some of them make us discouraged and hopeless”. (FG3)
Moreover, GPs complained about constraints imposed
by the healthcare system that sometimes limit their au-
tonomy, and make it difficult to prescribe according to
guidelines. A particularly difficult situation for GPs to
handle is when they find out that the medication that is
recommended according to best practice guidelines is
not reimbursed in their country (in Belgium by RIZIV/
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Insurance), or when reimbursement is contingent either
on prior authorization from RIZIV/INAMI, or the need
that patients visit specialists instead of GPs (as is the
case for patients with type 1 diabetes in Belgium).
Discussion
The results of our group interviews show that non-
adherence to guidelines in general practice should not
be systematically labeled CI. The Belgian health-care sys-
tem is characterized by fee-for-service, free access to all
levels of care, mostly small single-handed practices in
primary care, no compulsory guidelines (which are avail-
able but are not strictly “followed”), no real quality as-
surance, and a tradition of hospital-centered disease-
oriented care, all of which can make GPs frustrated
about working conditions. Despite this, the GPs in our
study displayed great commitment to their work, and
believed that prevalent definitions of CI did not take suf-
ficiently into account the active role of the patient in the
consultation and medical decision-making process, nor
the breadth and complexity of their role, which includes
tackling sociocultural determinants of health as much as
medical and pharmacological ones.
When situations of CI were actually acknowledged,
these were more often connected with a lack of investi-
gation to timely diagnose and treat a problem than with
failing to prescribe more. Insufficient delivery of health-
promotion and patient-education messages were consid-
ered a form of CI as well. Across a variety of cases of CI
in which patient and system factors were involved, feel-
ings of being overwhelmed and disempowered was a
common issue that emerged as an important factor of
CI. Again, appropriate decisions not to adhere to guide-
lines in specific situations, for specific patients, at spe-
cific times are not to be mistaken for CI. As far as
prescriptions are concerned, the participants in our
study saw their decisions as appropriate most of the time
although they were not always concordant with guide-
lines. Hence, the definition by Philips et al. [1], which
emphasizes prescription failures, was considered too
narrow, and irrelevant to general practice.
At the heart of evidence-based medicine is the pro-
viders’ capacity to integrate individual clinical expertise
with the best available clinical evidence from systematic
research [17]. Although the concept of CI arises in the
context of evidence-based practices, attempts to define it
tend to overlook the importance of adjusting care in in-
dividual cases. Indeed the main ways of measuring CI,
which are based on target, timeframe, and decision to
intensify therapy (or not) [2,4] are not sufficient to de-
termine whether individual decisions to increase or not
increase therapy might be appropriate for a specific pa-
tient [18,19]. As reflected by the participants in ourstudy, in order to adequately assess CI, it is necessary to
define intermediate outcomes that incorporate informa-
tion on, and justification of treatment decisions that are
made [20]. In the absence of such information, CI may
be only apparent, and actually reflect good clinical prac-
tice [18].
Application of clinical guidelines in the real world is
somewhat problematic because there are practitioner,
patient and system variables at play. However, clinicians
only have direct control over the first. Finally, the use of
the word ‘inertia’ to define a concept in Medicine (which
would be better described as inaction) may initially have
resulted from the mistaken belief that ‘inertia’ in Physics
actually implies some obstacle or reluctance in changing
motion. Describing the choice to maintain treatment with-
out any change as ‘inert’ can give the incorrect impression
of lethargy, and is rather debatable semantically.
The main strengths of our study lie in the number of
group interviews and the total number of participants
across the country, aiming for saturation of the data and
internal validity. Independent coding by two researchers
and discussions at several stages with a scientific com-
mittee including representatives of several medical speci-
alities and two GPs, are another strength of our study.
Regarding the researchers’ characteristics that might
have influenced the study, whereas one researcher (first
author) is very experienced in conducting qualitative re-
search in the field of health care and clinical communica-
tion, the other researcher (second author) is a research
nurse with extensive clinical experience and thorough
knowledge of evidence-based practice. A strength of the
study therefore lies in their complementarity to conduct
the study. Moreover, none of them is a medical doctor. Al-
though it might be argued that professions other than
physicians are not given enough credence by physicians in
other circumstances, we believe that this was a strength
for our study, as we approached the physicians without a
priori representations of how they should be dealing with
the risk of CI in their practice. The main limitation lies
with our choice of group interviews. Although it enabled
us to collect useful information on physicians’ opinions re-
garding the much debated concept of CI, in-depth individ-
ual interviews might have yielded richer data regarding
personal experience of CI.Conclusions
Our results suggest that non-adherence to clinical guide-
lines should not be labelled CI in the absence of careful in-
vestigation of the patient’s role and the physician’s motives
regarding decisions not to act or to postpone therapeutic
action in some situations. We believe that the term CI
could potentially increase the already existing gap between
general practice and specialised care, whereas sustained
Aujoulat et al. BMC Family Practice  (2015) 16:13 Page 6 of 6efforts toward more collaborative work and integrated
care are called for.
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